ArticleClinical and translational radiation oncology2023

Salvage radiotherapy for relapsed/refractory non-Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapy.

Nikhil Yegya-Raman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.